SCHEMBL19919611

SCHEMBL19919611

N#Cc1ccc(-c2ccc3c4ccc(-c5ccc(C#N)cc5)cc4n(-c4cc(C#N)cc(-n5c6cc(-c7ccc(C#N)cc7)ccc6c6ccc(-c7ccc(C#N)cc7)cc65)c4-c4ccncc4)c3c2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 2/20 0.42
CHEK1 O14757 3/20 0.40
MAPK14 Q16539 2/20 0.39
CSNK1A1 P48729 1/20 0.39
CSNK1D P48730 1/20 0.39
BRAF P15056 1/20 0.39
KDR P35968 1/20 0.39
CYP11B2 P19099 2/20 0.37
LRRK2 Q5S007 1/20 0.36
GCGR P47871 1/20 0.36
METAP2 P50579 1/20 0.36
CYP11B1 P15538 1/20 0.35
GSK3A P49840 1/20 0.35
GSK3B P49841 1/20 0.35
MAP4K4 O95819 1/20 0.35
PKN1 Q16512 1/20 0.34
PKN2 Q16513 1/20 0.34
CYP19A1 P11511 1/20 0.34
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19909478 0.94 FLT3 (0.41) FLT3CHEK1MAPK14CSNK1A1CSNK1D
SCHEMBL19909508 0.94 CHEK1 (0.42) FLT3CHEK1MAPK14CSNK1A1CSNK1D
SCHEMBL19913152 0.92 IMPDH2 (0.39) FLT3MAPK14CSNK1A1CSNK1DCYP11B2
SCHEMBL19909119 0.92 FLT3 (0.37) FLT3CHEK1MAPK14CSNK1A1CSNK1D
SCHEMBL19913161 0.91 FLT3 (0.40) FLT3CHEK1MAPK14CSNK1A1CSNK1D
SCHEMBL19909036 0.91 FLT3 (0.39) FLT3MAPK14CSNK1A1CSNK1DBRAF
SCHEMBL19909507 0.90 MAPK14 (0.42) FLT3CHEK1MAPK14CSNK1A1CSNK1D
SCHEMBL19913150 0.89 MAPK14 (0.39) FLT3MAPK14LRRK2GSK3AGSK3B
SCHEMBL19909476 0.89 AURKA (0.41) FLT3MAPK14GSK3AGSK3BMAP4K4
SCHEMBL19908940 0.88 GRM5 (0.39) FLT3CHEK1MAPK14CSNK1A1CSNK1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588114-B2 Organic molecules for use in optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-21 US disclosed
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-07-02 US disclosed
US-10665792-B2 Organic molecules for use in optoelectronic devices CYNORA GMBH (DE) 2020-05-26 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OPRM1, OR51E2 FLT3 2571/4885CHEK1 3673/4885MAPK14 2544/4885
US-10665792-B2 Organic molecules for use in optoelectronic devices OR10J3, CFD, AOX1 FLT3 3269/4885CHEK1 2506/4885MAPK14 2787/4885
US-11588114-B2 Organic molecules for use in optoelectronic devices OR10J3, OPRM1, OR51E2 FLT3 2571/4885CHEK1 3673/4885MAPK14 2544/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.